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Currently, there is great interest in the experi- 
mental technique of endovascular ortic aneurysm 
repair. The number of reports in the literature has 
increased in the past 5 years. The ability to inter- 
pret future clinical reports and to compare the 
advantages and disadvantages of the various de- 
vices and techniques requires a uniform standard 
for analyzing and reporting the data. Previous ex- 
perience with reports on the other endovascular 
devices (including percutaneous transluminal an- 
gioplasty, atherectomy catheters, and lasers) has 
clearly shown that investigators, left on their own, 
may report their results in a variety of ways, which 
make comparison of one report to the other diffi- 
cult, if not impossible. Consequently, to provide 
valid comparisons among reported results of endo- 
vascular management methods for abdominal aor- 
tic aneurysm, disease, the following guidelines are 
recommended. 
PATIENT ASSESSMENT 
Clinical classification 
In addition to the classification categories recom- 
mended in the SVS/ISCVS' Suggested Standards for 
Reporting on Arterial Aneurysms, 1 patients under- 
going endograft repair should be stratified by symp- 
toms and clinical presentation, asfollows: 
Stage I: Asymptomatic 
Stage II: Intact but symptomatic 
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Stage III: Contained rupture 
Stage IV'. Free rupture 
Patients with dissecting aneurysm should be cat- 
egorized separately because the complexity and tech- 
nical challenge of treating this disease are greater. 
Hemodynamic assessment 
Preoperative r sting anlde-brachial indexes (ABI) 
are needed as a baseline to help determine the s ver- 
ity of any thrombotic or embolic omplications after 
synergy. In diabetic patients ~th  noncompressible 
arteries, alternative tests should include toe pres- 
sures, pulse volume recording, or Doppler wave- 
form, as recommended by the Ad Hoc Subcommit- 
tee on Reporting Standards. 2,3 
Risk factors 
Patient demographic and risk factor variables 
should be reported, including tobacco use, hyper- 
tension, diabetes mellitus, hyperlipidemia, chronic 
obstructive pulmonary disease, cardiac disease, ca- 
rotid occlusive disease, renal insufficiency, and 
presence of other aneurysms using the criteria in 
the SVS/ISCVS standards and guidelines. >3 Anes- 
thetic risk should be reported according to the 
American Society of Anesthetist Risk Classification 
(ASA I-IV). 
Anatomic characteristics 
The technical difficulty of endovascular repair is 
greatly influenced by the morphologic features of the 
aneurysm and its adjacent vessels. Accordingly, the 
following characteristics should be individually re- 
corded and reported for each aneurysm, and the 
following grading scheme for these characteristics 
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Fig. 1. Grade I extent of aneurysm involvement: length 
of proximal neck 1.5 cm or greater and distal neck 1.0 cm 
or greater. 
should be used in stratifying the aneurysms for anal- 
ysis. 
1. Greatest mural diameter of  abdominal aortic an- 
eurysm (CT scan measurement):  
Small (S): Less than 5 cm. 
Medium (M): 5 to 6.5 cm. 
Large (L): Greater than 6.5 cm. 
2. Extent of  aneurysm involvement: 
Grade I: Length of  proximal neck ->1.5 cm and 
distal neck ->1.0 cm (Fig. 1). 
Grade II: Length of  proximal neck ->1.5 cm, but 
distal neck < 1.0 cm without obvious 
iliac aneurysms (Fig. 2, A), or aneu- 
rysm extends into or is associated 
with iliac aneurysms (Fig. 2, B). 
Grade I I I :  Length of  proximal neck <1.5 cm and 
distal neck ->1.0 cm (Fig. 3). 
Grade IV: Length of  proximal neck <1.5 cm and 
distal neck <1.0  cm or iliac involve- 
ment  as in Grade I I  (Fig. 4). 
3. Tortuosity of  aorta--because ofmultiple angles, the 
worst (greatest) angle should be used in grading: 
A 
JL 
<1 . ~  
JL 
B 
Fig. 2. A, Grade II extent of aneurysm involvement: 
length of proximal neck 1.5 cm or greater, but distal neck 
less than 1.0 cm without obvious iliac aneurysms, or B, 
aneurysm extends into or i-s associated with iliac aneurysms. 
Gradc I: 180 ° to 150 ° (180 ° = straight aortawith- 
out any tortuosity) (Fig. 5). 
Grade II: 150 ° to 120 ° (Fig. 6). 
Grade I I I :  Less than 120 ° (Fig. 7). 
4. Anatomy of  the iliac arteries: 
The absence or presence of  iliac artery occlusive 
disease, which requires intervention (i.e., balloon 
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Fig. 3. Grade III extent ofaneurysm involvement: length 
of proximal neck less than 1.5 cm and distal neck 1.0 cm or 
greater. 
.JL 
<1.5 cm 
<1.0 cm 
Fig. 4. Grade IV extent ofaneurysm involvcment: length 
of proximal neck less than 1.5 cm and distal neck less than 
1.0 cm or iliac involvement asin grade II. 
angioplasty) for any reason, including the intro- 
duction of the endograft cartier system, should be 
noted and designated as A (absent) or B (present). 
The least diameter of the iliac arteries hould be 
recorded as suggested by Veith et al. 4 Similarly, the 
absence or presence of lilac tormosity severe nough 
to require intervention (i.e., mobilization to 
straighten out a tortuous iliac artery or transretro- 
peritoneal temporary attachment of a prosthetic 
graft to the iliac artery) should bc designated as N 
(nontormous) or T (tortuous). The actual number 
or percentage ofthese patients hould be reported. 
An asymptomatic 6.0 cm, "straight" aortic aneu- 
rysm, with good proximal and distal necks and with- 
out stenotic or tortuous iliac arteries, would be cate- 
gorized as Clinical Stage I, Size M, Neck Grade I, 
Angle Grade I, Iliac A,N. These anatomical charac- 
teristics hould be based on a combination or aorto- 
graphic and computed tomographic (CT) or mag- 
netic resonance (MR) imaging scans, preferentially 
with three-dimensional reconstruction when avail- 
able. Both aortographic and CT /MR imaging meth- 
ods are required to allow precise measurement of the 
characteristics li ted above. 
DEVICE-RELATED FACTORS 
The devices and grafts should be classified ac- 
cording to their configuration (straight vs bifurcat- 
ed); the material used (Dacron vs PTFE vs polyure- 
thane,  etc.); the type of fixation system and 
manufacturer of the device4; and the diameter of the 
proximal and distal fixation sites. 
PHARMACOLOGIC  THERAPY 
Adjunctive pharmacologic therapy such as aspi- 
rin, hepatin, sodium, coumadin, vasodilators, 
and/or thrombolytic agents, along with their dosage 
and duration of treatment, should be described. The 
type and volume of contrast agent used during the 
procedure should be documented. 
MISCELLANEOUS FACTORS 
Type of anesthesia (general, spinal, local, etc.), 
duration of surgery (skin open to skin closure), esti- 
mated blood loss, and transfusion (within 24 hr) 
JOURNAL OF VASCULAR SURGERY 
408  Ahn et al. February 1997 
JL JL 
150 ° 
Fig. 5. Grade I tortuosity of aorta: 180 ° to 150 °. Fig. 6. Grade II tortuosity of aorta: 150 ° to 120 °. 
should be reported. Furthermore, the point of entry 
or approach (i.e., femoral vs iliac vs brachiocephalic 
artery cutdown vs percutaneous route) should be 
recorded and reported. 
CRITERIA FOR SUCCESS 
Technical success 
Treatment outcome must be based on intent-to- 
treat and includes all patients who consent o un- 
dergo the procedure. Technical success is defined as 
the proper placement of the graft by using endovas- 
cular techniques. This involves the following: 
. 
. 
Successful access to the arterial system using a 
remote site, i.e., the femoral, external i iac, com- 
mon ifiac, or brachiocephalic arteries with or 
without use of a temporary or permanent pros- 
thetic conduit o access these arteries. 
Successful deployment of the endoluminal graft 
with secure proximal and distal fixation of the 
attachment devices without persistent perigraft 
endoleakage. Small, transient (<48 hr) perigraft 
extravasation f  the contrast medium through the 
graft interstices or around the graft (an endoleak) 
should be recorded and reported, but is not con- 
. 
sidered a leak or a technical failure. However, a 
persistent leak (->48 hr) of blood through the 
graft or an endoleak around the proximal or distal 
ends of the graft constitutes a failure, even if it is 
not treated. 
Patent endoluminal graft without significant 
twist, ldnks, or obstruction (<20%) by intraoper- 
ative angiogram diameter measurements. 
Technical success must be documented by oper- 
ative aortographic s an and follow-up CT scan, color 
Duplex scan, or angiogram. Intravascular ultra- 
sonography may be a helpful adjunct but is not 
required. The inability to gain aortic access through a
remote site, to properly deploy the graft, to properly 
secure the graft without leak, or need for conversion 
to standard aortic reconstruction for any reason 
should be considered a technical failure. 4
The technical success without death or need for 
standard aortic reconstruction must be maintained 
for 30 days for the procedure to be considered suc- 
cessful, Reports should also include the range and 
average number of days on a ventilator, in an inten- 
sive care unit, and in the hospital. Furthermore, re- 
porting the average hospital charges and cost per 
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patient is recommended. Finally, if available, the 
number of days to return to the preprocedure daily 
activity level and patient satisfaction should be re- 
ported. If so, the precise definitions and techniques 
for determining these factors must be explained. 
Clinical success 
Clinical success is defined similarly to technical 
success except for the presence or absence of peri- 
graft endoleak. This exception is important because 
small endoleaks may seal spontaneously without 
treatment, and the patients ubsequently have done 
well. Thus clinical success (although a technical fail- 
ure) can still be claimed, even if the patient has a 
persistent endoleak that seals spontaneously within 6 
months and does not develop aneurysmal expansion 
or rupture. Graft endoleaks that persist longer than 6 
months or aneurysms that expand should be consid- 
ered clinical failures because late rupture has been 
reported under such circumstances. Any subsequent 
intervention directed at the above events also consti- 
tute clinical failure. 
Continuing success 
Continuing success is defined as maintenance of
the technical and clinical success with no evidence of 
graft thrombosis, migration, infection, or dilatation 
greater than 20% by diameter; aneurysmal degenera- 
tion proximal or distal to the graft; fixation device 
failure; aneurysmal expansion by 0.5 cm or greater; 
or requirement for open conversion. Any occurrence 
of such adverse outcomes constitutes failure of the 
procedure. Any other easons for graft replacement 
using open techniques should also be considered a 
failure. Any late graft complications that are success- 
fully treated with another endovascular o other less- 
invasive procedure (i.e., another graft or stent in- 
serted for stenosis, dilatation, persistent leal~s, or to 
control migration) that does not replace the original 
graft can be counted as a secondary success. 
Duration of successful outcome is considered 
short-term if the above requirements are met for 6 
months, midterm if aintained for 2 years, and long- 
term after 5 years. 
Life tables or Kaplan-Meier curves hould be cal- 
culated to record data on maintenance of technical 
and clinical success. These overall results hould also 
be dissected to present separately survival, rupture- 
free survival, stability of aneurysm size, and graft 
patency. Late results require at least 5 year follow-up. 
Results of 2- to 5-year follow-up are considered mid- 
term or intermediate. Follow-up less than 6 months 
should be reported as preliminary short-term data. 
Fig. 7. Grade III tortuosity of aorta: less than 120 °. 
COMPLICATIONS 
Local vascular complications 
Bleeding is considered a complication if surgical 
treatment or transfusion of more than 2 units of 
blood are required. The range and average volumes 
of estimated blood loss and transfusion requirements 
should bc rccorded. A hematoma or pseudoaneu- 
rysm at any access ite should be reported if further 
treatment (medical or surgical) is required or if hos- 
pital discharge is delayed. An infection is considered 
to be present if the access site or the endoluminal 
graft are involved. Thromboembolic complications 
include distal emboli, graft thrombosis, or access ite 
thrombosis. Intestinal ischemia should be listed as a 
separate complication. If a perigraft endoleak is 
treated conservatively, comprehensive follow-up 
evaluation is required. Any aneurysmal rupture or 
death must bc reported. 4 Late migration of the graft 
or attachment device failure or defects must be re- 
ported. 
Remote systemic complications 
Other procedural complications that must be re- 
ported include myocardial infarction, cardiac failure, 
renal failure, respiratory failure, pneumonia, telecta- 
sis, hepatic failure, urinary tract infection, coagulopa- 
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thies, hypercoagulable states, and fever. 4 Renal fail- 
ure requires particular attention, because the most 
common cause is a large contrast load, which may 
reflect technical problems. These must be reported 
and defined as recommended.  1,2 Any death within 
30 days regardless of  cause is considered a procedure- 
related death. 
FOLLOW-UP DATA 
A follow-up protocol  should include clinical sta- 
tus and physical examination, ABI, and a contrast- 
enhanced CT scan at least every 6 months. Ancurysm 
size and lack of  contrast enhancement (leak) outside 
the endograft must be documented.  A duplex scan or 
aortogram is recommended but not  required unless 
clinically indicated to clarify abnormalities found by 
the required studies, 4 that is, to evaluate endoleaks, 
kinks, or narrowing of  endograft. Plain x-ray films 
should be obtained to detect defects in the fixation 
devices. 
CONCLUDING REMARKS 
These recommendations are based on current 
knowledge of  the new technology. Because this field 
is still evolving, it is quite likely that modifications of  
these reporting standards will be required. Neverthe- 
less, these guidelines provide uniformity in reporting 
so that the various devices can be analyzed and com- 
pared. 
We thank Blessie Concepcion for her assistance in the 
preparation of this manuscript. 
REFERENCES 
1. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier 
L, Stanley JC. Suggested standards for reporting on arterial 
aneurysms. J Vasc Surg 1991;13:452-8. 
2. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Kar- 
mody A, Whittemore AD, et al. Suggested standards for re- 
ports dealing with lower extremity ischemia. J Vase Surg 1986; 
4:80-94. 
3. Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston 
ICvV, McClean GK, et al. Reporting standards for lower extrem- 
ity arterial endovascular procedures. J Va c Surg 1993;17: 
1103-7. 
4. Veith FJ, Abbott WM, Yao JST, Goldstone J, White RA, Abel 
D, et al. Guidelines for development and use oftransluminally 
placed endovascular prosthetic grafts in the arterial system. J 
Vase Surg 1995;21:670-85. 
Submitted Aug. 30, 1996; accepted Nov. 1,1996. 
